Delivery Order SPE2DB22D3501-SPE2DB25FTL76

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a medical product. The $1,580.79 firm fixed-price delivery order contract has an ultimate completion date of January 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Advair HFA 230-21 MCG Inhaler 12GM. The $4,888.78 firm fixed-price delivery order has a period of performance through May 8, 2024. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Advair HFA 115-21 MCG inhalers to the Defense Logistics Agency (DLA). The $5,650.82 firm fixed price delivery order has a completion date of November 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,975.72 firm-fixed-price delivery order contract is for the provision of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The $7,387.08 firm fixed price contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,574.70 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, to support military treatment programs and facilities. The contract has an ultimate completion date of September 4, 2024 and was awarded on September 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA). The $12,614.53 firm fixed-price delivery order has a completion date of June 21, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $4,113.24 with a completion date of January 2, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $1,860.84 delivery order contract has a firm fixed-price pricing structure and an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.96 delivery order is for the supply of an Advair HFA 230-21 MCG inhaler product. The contract has a firm fixed price and an ultimate completion date of June 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTL76
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Advair HFA 230-21 MCG inhalers to support federal healthcare programs. The $3,338.86 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 2/11/25, 10:24 AM